Building Blocks
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,778 products)
- Chiral Building Blocks(1,243 products)
- Hydrocarbon Building Blocks(6,099 products)
- Organic Building Blocks(61,038 products)
Found 205376 products of "Building Blocks"
Methacryloxypropyl terminated polydimethylsiloxanes
CAS:MW 20,000 - 30,000
Formula:C20H40O6Si3Purity:Min. 95%Molecular weight:460.8 g/molBenzyl N,N,N',N'-Tetraisopropylphosphorodiamidite
CAS:Benzyl N,N,N',N'-tetraisopropylphosphorodiamidite is a reagent that reacts with hydroxybenzyl amine to form an ester. This product is used for the synthesis of phosphoramidites and benzyl esters. It is also used as a catalyst for the synthesis of diesters.Formula:C19H35N2OPPurity:Min. 95%Molecular weight:338.48 g/mol1-Boc 3-(2-bromoethyl)pyrrolidine
CAS:Versatile small molecule scaffoldFormula:C11H20BrNO2Purity:Min. 95%Molecular weight:278.19 g/mol2-[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]propan-2-ol
CAS:Versatile small molecule scaffoldFormula:C13H21BN2O3Purity:Min. 95%Molecular weight:264.13 g/mol3-Bromo-5-cyanobenzaldehyde
CAS:Versatile small molecule scaffoldFormula:C8H4BrNOPurity:Min. 95%Molecular weight:210.04 g/mol3-[5-(Aminomethyl)-1-oxo-2,3-dihydro-1H-isoindol-2-yl]piperidine-2,6-dione hydrochloride
CAS:Versatile small molecule scaffoldFormula:C14H16ClN3O3Purity:Min. 95%Molecular weight:309.75 g/mol2-Methoxy-benzenesulfonic acid
CAS:2-Methoxy-benzenesulfonic acid is a synthetic chemical compound that is used in the production of polymers and other ester compounds. It can be produced by reacting benzenesulfonyl chloride with methanol in the presence of a strong acid catalyst. 2-Methoxy-benzenesulfonic acid reacts with radiation to produce reactive oxygen species that are capable of damaging cellular structures. The molecule contains an intramolecular hydrogen bond, which stabilizes the structure and helps to form hydrogen bonds with other molecules. 2-Methoxy-benzenesulfonic acid also has a hydroxyl group, which allows it to function as an acidic compound that can react with water and cause inflammation. This functional group also makes it soluble in water, allowing it to penetrate tissue structures.
Formula:C7H8O4SPurity:Min. 95%Molecular weight:188.2 g/mol3-Methoxy-benzenesulfonic acid
CAS:Versatile small molecule scaffold
Formula:C7H8O4SPurity:Min. 95%Molecular weight:188.2 g/mol(4-(tert-Butoxy)phenyl)methanamine
CAS:(4-(tert-Butoxy)phenyl)methanamine (BPMT) is a ligand that binds to the alpha-2 receptor and acts as an antagonist. This compound has been shown to be a molecular target for positron emission tomography imaging, which is used in the diagnosis of tumours. BPMT is also used in the treatment of neuropeptide-associated disorders such as Parkinson's disease. The chiral nature of this compound makes it useful for the production of radiopharmaceuticals and other diagnostic agents with different physical properties.Formula:C11H17NOPurity:Min. 95%Molecular weight:179.26 g/mol8-Methylnonan-1-ol
CAS:Please enquire for more information about 8-Methylnonan-1-ol including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C10H22OPurity:Min. 95%Molecular weight:158.28 g/mol5-Bromo-1-methyl-3H-1,3-benzodiazol-2-one
CAS:Versatile small molecule scaffoldFormula:C8H7BrN2OPurity:Min. 95%Molecular weight:227.06 g/molN-Ethylcyclobutanamine hydrochloride
CAS:Versatile small molecule scaffoldFormula:C6H13NPurity:Min. 95%Molecular weight:99.17 g/molBMS-986165
CAS:Controlled ProductBMS-986165 is a P-glycoprotein (P-gp) inhibitor that has been shown to reduce the absorption of ciclosporin, tacrolimus, and everolimus in vitro. BMS-986165 has an activity index of 100% and inhibits the inflammatory response by inhibiting the production of cytokines. It has been found to be effective for treating bowel diseases, such as ulcerative colitis and Crohn's disease. The drug also may be used for the treatment of autoimmune diseases, such as psoriasis or rheumatoid arthritis. BMS-986165 is administered orally and is rapidly absorbed. It is metabolized by CYP3A4 and excreted in urine as metabolites. END>> END>>Formula:C20H19D3N8O3Purity:Min. 95%Molecular weight:425.46 g/molSodium 2,3-dihydroxypropane-1-sulfonate
CAS:Sodium 2,3-dihydroxypropane-1-sulfonate is a granular detergent that can be used in the production of heavy duty liquid and solid granules. It is an anionic surfactant with a sulfonate group that has a granular consistency. This detergent is often used as a wetting agent in detergents and as a dispersing agent in paints, dyes, and pharmaceuticals. Sodium 2,3-dihydroxypropane-1-sulfonate has been shown to be effective at removing particulate matter from water and can also be used as a stabilizer for other surfactants during manufacturing.Formula:C3H7NaO5SPurity:Min. 95%Molecular weight:178.14 g/mol3,5-Bis(trifluoromethyl)-1H-pyrazole-4-carboxylic acid
CAS:3,5-Bis(trifluoromethyl)-1H-pyrazole-4-carboxylic acid is a chiral compound that has been shown to be an active building block for coordination frameworks. It is prepared from the reaction of 3,5-bis(trifluoromethyl)-1H-pyrazole with a carboxylic acid and can be used in the synthesis of metalloporphyrins. 3,5-Bis(trifluoromethyl)-1H-pyrazole-4-carboxylic acid has been shown to form stable coordination complexes with ligands such as bidentate or tridentate phosphoramidites and dimethylammonium chloride. This compound undergoes thermal treatment during the preparation process and reacts with various solvents and reagents.Formula:C6H2F6N2O2Purity:Min. 95%Molecular weight:248.08 g/mol1-chloro-4-fluoroisoquinoline
CAS:1-chloro-4-fluoroisoquinoline is a chlorinating agent that has been used as a synthetic method for the synthesis of oxychloride. It is typically used in the presence of palladium catalyst, in the presence of phosphorus and under reductive conditions. The chlorination reaction is initiated by addition of hydrochloric acid or phosphorous oxychloride. The 1-hydroxyisoquinoline reacts with phosphorus to form a chloroformate, which reacts with fluorine gas to produce an intermediate chlorofluorinate. This intermediate then reacts with chlorine gas in the presence of palladium catalyst to generate the desired product, 1-chloro-4-fluoroisoquinoline.Formula:C9H5ClFNPurity:Min. 95%Molecular weight:181.59 g/mol2,7-Naphthyridin-1(2H)-one
CAS:Cabozantinib is a small molecule that is the first to target VEGFR-2, which is a receptor tyrosine kinase involved in the development of fibrosis. Cabozantinib inhibits the activity of VEGFR-2 by binding to its ATP-binding site and blocking the phosphorylation of downstream signaling pathways. Cabozantinib has been shown to have antifibrotic properties in both preclinical and clinical models. The drug candidate has been shown to reduce kidney fibrosis in animal models. The standard dose for cabozantinib was found to be 5 mg/kg, with a maximum tolerated dose of 20 mg/kg. In vitro studies have indicated that cabozantinib binds with high affinity to the ATP-binding pocket of VEGFR-2, exhibiting competitive inhibition against other kinases such as PDGFR-beta and cKit, as well as diaryliodonium (a specific inhibitor). Caboz
Formula:C8H6N2OPurity:Min. 95%Molecular weight:146.14 g/mol6-Bromo-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one
CAS:Versatile small molecule scaffold
Formula:C8H6BrNO2Purity:Min. 95%Molecular weight:228.04 g/mol(3-Aminopropyl)(3-phenylpropyl)amine
CAS:Versatile small molecule scaffoldFormula:C12H20N2Purity:Min. 95%Molecular weight:192.3 g/molMethyl 2-amino-5-pyridin-3-yl-1,3-thiazole-4-carboxylate
CAS:Versatile small molecule scaffoldFormula:C10H9N3O2SPurity:Min. 95%Molecular weight:235.26 g/mol
![2-[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]propan-2-ol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FUCC25587.webp&w=3840&q=75)
![3-[5-(Aminomethyl)-1-oxo-2,3-dihydro-1H-isoindol-2-yl]piperidine-2,6-dione hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIWB26469.webp&w=3840&q=75)
